Facebook Twitter Gplus YouTube Google Maps RSS
 
 
Home » Bad Drug » Archive for category "Pradaxa"

Archive for the ‘Pradaxa’ Category:


No Reversing Agent to Stop Bleeds in Pradaxa Users

For patients that take Pradaxa (dabigatran) and suffer a bleed into the brain or elsewhere, there is currently no fast, effective way to reverse the blood-thinning agent’s effects, reports The Los Angeles Times.   This is the latest of immediate concerns involving the anticoagulant, Pradaxa. Earlier this week the Journal of Neurosurgery publication released a case study

Read More::

It Takes a Death to Raise Concerns with Pradaxa Bleeds?!

The death of an elderly man, who suffered from a simple ground-level fall and, in turn, suffered a massive brain bleed, is raising serious concerns about the significant bleeding dangers associated with Pradaxa (dabigatran), according to a recent publication in the Journal of Neurosurgery. Researchers, Sarah T. Garber, M.D., Walavan Sivakumar, M.D., and Richard H.

Read More::

Pradaxa Bleeds Prompt Audit of Bleed Incidents

The thrombin inhibitor dabigatran (Pradaxa) has been available to patients with atrial fibrillation for stroke prevention in New Zealand since July 2011.  However, the issue of potentially fatal bleeds immediately concerned hematologists, which prompted them to audit the bleed events with the Haematology Society of Australia and New Zealand, according to The New England Journal of Medicine

Read More::

Ennis & Ennis, P.A. Investigates Pradaxa Bleed Claims

On December 7, 2011, the U. S. Food and Drug Administration (FDA) issued a Safety Communication reporting that it was investigating reports of serious and fatal bleeds in patients taking Pradaxa. Pradaxa is a blood thinning medication (anticoagulant) used to reduce the risk of stroke and blood clots in patients with non-valvular atrial fibrillation (AF). David Ennis of Ennis & Ennis,

Read More::

 
© Ennis & Ennis, P.A.

Switch to our mobile site